Skellerup led the bourse higher with exporters benefitting from a weaker currency.
USX-listed company, trading as Waitaki Biosciences, has been exploring capital raising avenues due to a working capital deficit.
Bremworth is finding there are still some believers in wool.
The boss of the listed jeweller says the company has been ‘more homogenous’ than it needed to be in the past.
The Commerce Commission is reviewing whether a deal to sell Bremworth to the owners of Godfrey Hirst will dampen competition in the New Zealand flooring market.
Vista shone in a flurry of earnings in February’s last trading.
Gareth Edgecombe is hopeful the market could become a material part of its portfolio.
Issue that led to failure has been identified and rectified, but fabrication of new tank will push timeline, says Sir Peter Beck.
The company is trading at a 23% discount to its net tangible asset price per share.
The wine maker has produced a solid half-year result despite tariff turmoil, grape over-supply, and dropping wine consumption.
